NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Smith MEB, Lee NJ, Haney E, et al. Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5 [Internet]. Portland (OR): Oregon Health & Science University; 2009 Nov.

Cover of Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin

Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5 [Internet].

Show details

Appendix BSearch strategy

Searches on Medline, Medline-In Process amd Cochrane Central Register of Controlled Trials were repeated in May-June of 2009 and gave additional citations that were reviewed and incorporated when they met eligibility criteria.

Database: Ovid MEDLINE(R) <1996 to January Week 4 2009>
Search Strategy:
1lovastatin.mp. or exp Lovastatin/(5022)
2simvastatin.mp. or exp Simvastatin/(3948)
3pravastatin.mp. or exp Pravastatin/(2578)
4atorvastatin.mp. (3245)
5fluvastatin.mp. (1073)
6rosuvastatin.mp. (726)
7exp Hydroxymethylglutaryl-CoA Reductase Inhibitors/or statin$.mp. (18571)
81 or 2 or 3 or 4 or 5 or 6 or 7 (20058)
9Comparative Study/(686468)
10drug evaluation studies.mp. or exp Drug Evaluation/(4285)
119 or 10 (689769)
128 and 11 (2374)
13limit 12 to humans (2036)
14limit 13 to english language (1761)
15limit 13 to abstracts (1812)
1614 or 15 (1964)
17exp clinical trials/or clinical trial$.mp. (380571)
18exp Cohort Studies/(431690)
19(cohort stud$ or longitudinal stud$ or prospective stud$).mp. (296276)
2017 or 18 or 19 (762070)
218 and 20 (5991)
22limit 21 to humans (5938)
23limit 21 to abstracts (5335)
2422 or 23 (5988)
2516 or 24 (6831)
26(2006$ not (200601$ or 200602$)).ed. (526925)
27(2007$ or 2008$ or 2009$).ed. (1409839)
2826 or 27 (1936764)
2925 and 28 (2347)
30from 29 keep 1–2347 (2347)
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations <February 05, 2009>
Search Strategy:
1lovastatin.mp. or exp Lovastatin/(74)
2simvastatin.mp. or exp Simvastatin/(233)
3pravastatin.mp. or exp Pravastatin/(108)
4atorvastatin.mp. (215)
5fluvastatin.mp. (38)
6rosuvastatin.mp. (79)
7exp Hydroxymethylglutaryl-CoA Reductase Inhibitors/or statin$.mp. (947)
81 or 2 or 3 or 4 or 5 or 6 or 7 (1313)
9Comparative Study/(3071)
10drug evaluation studies.mp. or exp Drug Evaluation/(2)
119 or 10 (3073)
128 and 11 (24)
13meta analysis.mp. or exp Meta-Analysis/(1529)
14multicenter study.mp. or exp Multicenter Study/(835)
15exp clinical trials/or clinical trial$.mp. (6900)
16exp Cohort Studies/(3)
17(cohort stud$ or longitudinal stud$ or prospective stud$).mp. (5885)
1813 or 14 or 15 or 16 or 17 (14494)
1912 or (8 and 18) (167)
20limit 19 to abstracts (161)
21from 20 keep 1–161 (161)
Database: EBM Reviews - Cochrane Central Register of Controlled Trials <4th Quarter 2008>
Search Strategy:
1lovastatin.mp. or exp Lovastatin/(1204)
2simvastatin.mp. or exp Simvastatin/(1167)
3pravastatin.mp. or exp Pravastatin/(949)
4atorvastatin.mp. (941)
5fluvastatin.mp. (368)
6rosuvastatin.mp. (143)
7exp Hydroxymethylglutaryl-CoA Reductase Inhibitors/or statin$.mp. (2749)
81 or 2 or 3 or 4 or 5 or 6 or 7 (3802)
9Comparative Study/or comparative study.mp. (12886)
10drug evaluation studies.mp. or exp Drug Evaluation/(5646)
119 or 10 (18324)
128 and 11 (90)
13meta analysis/or meta analysis.mp. (1027)
14multicenter study/or multicenter study.mp. (6897)
15exp clinical trials/or clinical trial$.mp. (82715)
16exp Cohort Studies/(73025)
17(cohort stud$ or longitudinal stud$ or prospective stud$).mp. (59519)
1813 or 14 or 15 or 16 or 17 (152832)
1912 or (8 and 18) (1240)
20limit 19 to abstracts (1190)
21from 20 keep 1–1190 (1190)
Database: Ovid MEDLINE(R) <1996 to January Week 4 2009>
Search Strategy:
1Advicor.mp. (9)
2Vytorin.mp. (16)
3Simcor.mp. (3)
4(lovastatin and niacin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (76)
5(simvastatin and ezetimibe).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (234)
6(simvastatin and niacin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (90)
7lovastatin.mp. or exp Lovastatin/(5022)
8simvastatin.mp. or exp Simvastatin/(3948)
9niacin.mp. or exp Niacin/(1922)
10niacin extended release.mp. (19)
11Niacin ER.mp. (21)
12(niacin adj3 extend$ release).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (94)
13ezetimibe.mp. (784)
14Zetia.mp. (26)
151 or 2 or 3 or 4 or 5 or 6 (355)
167 or 8 (5572)
179 or 10 or 11 or 12 or 13 or 14 (2624)
1816 and 17 (361)
1915 or 18 (363)
20from 19 keep 1–363 (363)
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations <February 05, 2009>
Search Strategy:
1Advicor.mp. (0)
2Vytorin.mp. (1)
3Simcor.mp. (0)
4(lovastatin and niacin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (2)
5(simvastatin and ezetimibe).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (25)
6(simvastatin and niacin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (11)
7lovastatin.mp. or exp Lovastatin/(74)
8simvastatin.mp. or exp Simvastatin/(233)
9niacin.mp. or exp Niacin/(99)
10niacin extended release.mp. (3)
11Niacin ER.mp. (3)
12(niacin adj3 extend$ release).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (16)
13ezetimibe.mp. (77)
14Zetia.mp. (1)
151 or 2 or 3 or 4 or 5 or 6 (34)
167 or 8 (284)
179 or 10 or 11 or 12 or 13 or 14 (170)
1816 and 17 (35)
1915 or 18 (35)
20from 19 keep 1–35 (35)
Database: EBM Reviews - Cochrane Central Register of Controlled Trials <4th Quarter 2008>
Search Strategy:
1Advicor.mp. (3)
2Vytorin.mp. (2)
3Simcor.mp. (1)
4(lovastatin and niacin).mp. (44)
5(simvastatin and ezetimibe).mp. (55)
6(simvastatin and niacin).mp. (20)
7lovastatin.mp. or exp Lovastatin/(1204)
8simvastatin.mp. or exp Simvastatin/(1167)
9niacin.mp. or exp Niacin/(297)
10niacin extended release.mp. (9)
11Niacin ER.mp. (13)
12(niacin adj3 extend$ release).mp. (42)
13ezetimibe.mp. (118)
14Zetia.mp. (3)
151 or 2 or 3 or 4 or 5 or 6 (112)
167 or 8 (1567)
179 or 10 or 11 or 12 or 13 or 14 (413)
1816 and 17 (113)
1915 or 18 (115)
20from 19 keep 1–115 (115)
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.
Bookshelf ID: NBK47272

Views

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...